AGPS-IN-1 is an alkylglycerone phosphate synthase (AGPS) inhibitor. AGPS-IN1 specifically reverses the epithelial-mesenchymal transition (EMT) process by upregulating E-cadherin (E-cadherin) and downregulating Snail and MMP2. AGPS-IN-1 can be used for the research of invasive tumors such as breast cancer and prostate cancer[1].
Molecular Weight:
345.34
Purity:
99.74
CAS Number:
[2316782-88-2]
Formula:
C18H17F2N3O2
Target:
Cadherin,MMP
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted